CN

Chetna Naresh Panchal

Active Director Director DIN 10071901
DIN 10071901 First appointment Mar 2023 Primary industry Machinery and Equipment
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Chetna Naresh Panchal

Data last updated:

Chetna Naresh Panchal is a Director at Bodhi Pharmatech Private Limited (since 2023). The company operates in Machinery and Equipment.

DIN 10071901
Primary Designation Director
Industry Machinery and Equipment
First Appointment 14 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bodhi Pharmatech Private Limited U28299MH2023PTC398947
Director14 Mar 20232023Active

Board colleagues of Chetna Naresh Panchal

NameDINCompanyDesignation
Priyanka Amit Pagare10071900Bodhi Pharmatech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bodhi Pharmatech Private Limited
Premium access

Shareholding and investment profile for Chetna Naresh Panchal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chetna Naresh Panchal

Chetna Naresh Panchal currently holds 1 directorship: Bodhi Pharmatech Private Limited (Director, since 14 Mar 2023).

Chetna Naresh Panchal was first appointed on 14 Mar 2023 as Director at Bodhi Pharmatech Private Limited.

The current boards of Chetna Naresh Panchal's companies include Priyanka Amit Pagare (Bodhi Pharmatech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available